Checkpoint Therapeutics Inc [CKPT] stock prices are down -0.74% to $4.01 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The CKPT shares have lost -0.74% over the last week, with a monthly amount glided 68.49%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Checkpoint Therapeutics Inc [NASDAQ: CKPT] stock has seen the most recent analyst activity on January 13, 2025, when D. Boral Capital initiated its Buy rating and assigned the stock a price target of $9. On June 09, 2021, B. Riley Securities initiated with a Buy rating and assigned a price target of $18 on the stock. Cantor Fitzgerald started tracking the stock assigning a Overweight rating and suggested a price target of $16 on January 20, 2021. Lake Street initiated its recommendation with a Buy. H.C. Wainwright started tracking with a Buy rating for this stock on December 08, 2017, and assigned it a price target of $11.
The stock price of Checkpoint Therapeutics Inc [CKPT] has been fluctuating between $1.38 and $4.50 over the past year. Currently, Wall Street analysts expect the stock to reach $4.1 within the next 12 months. Checkpoint Therapeutics Inc [NASDAQ: CKPT] shares were valued at $4.01 at the most recent close of the market. An investor can expect a potential return of 2.24% based on the average CKPT price forecast.
Analyzing the CKPT fundamentals
The Checkpoint Therapeutics Inc [NASDAQ:CKPT] reported sales of 0.04M for trailing twelve months, representing a drop of -100.00%. Gross Profit Margin for this corporation currently stands at -315.51% with Operating Profit Margin at -1370.1%, Pretax Profit Margin comes in at -1371.71%, and Net Profit Margin reading is -1371.71%. To continue investigating profitability, this company’s Return on Assets is posted at -7.53, Equity is 4.39 and Total Capital is 4.45.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 3.99 points at the first support level, and at 3.97 for the second support level. However, for the 1st resistance point, the stock is sitting at 4.03, and for the 2nd resistance point, it is at 4.05.
Ratios To Look Out For
It’s worth pointing out that Checkpoint Therapeutics Inc [NASDAQ:CKPT]’s Current Ratio is 0.37. As well, the Quick Ratio is 0.37, while the Cash Ratio is 0.33. Considering the valuation of this stock, the price to sales ratio is 8397.25.
Transactions by insiders
Recent insider trading involved Oliviero James F III, CEO, President and Director, that happened on Apr 02 ’25 when 15090.0 shares were sold. Chief Financial Officer, GRAY WILLIAM GARRETT completed a deal on Apr 01 ’25 to sell 12322.0 shares. Meanwhile, CEO, President and Director Oliviero James F III sold 10331.0 shares on Feb 10 ’25.
